Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.
Total Global Data
Last Updated: May 8, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
Clinical and genetic study of Unusual/Familial Movement Disorders
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Clinicogenetic Study of PD in Tunisia
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
CORIELL
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowCSF Biomarkers
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
DATATOP
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
DeNoPa
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
DIGPD
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
DLB Cohort TLVMC
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
ELPD Project
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Familial and Early-onset PD Database
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
